Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-interventional Observational Study With Viramune® Plus Antiretroviral Backbone Combination in HIV-infected Women and Male Patients. Gender Specific Evaluation of Data.

NCT01134939 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT01134939
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01134939 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-interventional Observational Study With Viramune® Plus Antiretroviral Backbone Combination in HIV-infected Women and Male Patients. Gender Specific Evaluation of Data.
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
May 31, 2010
Completion date
December 31, 2013
Enrollment
265 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections